Select Your Language

Login To MyFDA

24/7 Live Chat Call Us

File U.S. FDA Drug Master Files in eCTD

As of May 5, 2018, FDA requires electronic common technical document (eCTD) format for Type II, Type IV, and Type V drug master file (DMF) submissions, including reports, amendments, and supplements.  FDA states that it will reject non-eCTD DMF submissions of these types.  Registrar Corp can submit documentation in eCTD to FDA on your behalf.

For assistance with FDA DMF eCTD requirements, simply complete the form below:

Search Registrar Corp

View Our Locations

Choose Your Language